|
CONSOLIDATED STATEMENTS OF OPERATIONS (Parentheticals) (USD $)
|
3 Months Ended | 9 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
|
Jul. 31, 2014
|
Jul. 31, 2013
|
Jul. 31, 2014
|
Jul. 31, 2013
|
Oct. 31, 2013
|
Oct. 31, 2012
|
|
| Stock Option Compensation Expense | $ 4,072,000 | $ 3,001,000 | ||||
|
Selling, General and Administrative Expenses [Member]
|
||||||
| Stock Option Compensation Expense | 469,481 | 1,237,838 | 2,346,587 | 2,692,798 | 3,798,139 | 492,032 |
|
Research and Development Expense [Member]
|
||||||
| Stock Option Compensation Expense | $ 233,233 | |||||
| X | ||||||||||
|
- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|